Phenotypic characterization of two novel cell line models of castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Phenotypic characterization of two novel cell line models of castration‐resistant prostate cancer

Published:2021-08-16 Issue:15 Volume:81 Page:1159-1171
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Haffner Michael C.¹²³⁴^ORCID,Bhamidipati Akshay⁴^ORCID,Tsai Harrison K.⁴⁵,Esopi David M.⁴,Vaghasia Ajay M.⁴,Low Jin‐Yih¹,Patel Radhika A.¹,Guner Gunes³⁶,Pham Minh‐Tam⁴,Castagna Nicole⁴,Hicks Jessica²,Wyhs Nicolas⁴,Aebersold Ruedi⁷⁸,De Marzo Angelo M.³⁴⁹,Nelson William G.³⁴⁹,Guo Tiannan⁷¹⁰,Yegnasubramanian Srinivasan³⁴^ORCID

Affiliation:

1. Divisions of Human Biology and Clinical Research Fred Hutchinson Cancer Research Center Seattle Washington USA

2. Department of Pathology University of Washington Seattle Washington USA

3. Department of Pathology Johns Hopkins University School of Medicine Baltimore Maryland USA

4. Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine Baltimore Maryland USA

5. Department of Pathology Brigham and Women's Hospital Boston Massachusetts USA

6. Department of Pathology Hacettepe University Faculty of Medicine Ankara Turkey

7. Department of Biology Institute of Molecular Systems Biology, ETH Zürich Switzerland

8. Faculty of Science University of Zürich Zürich Switzerland

9. Department of Urology, James Buchanan Brady Urological Institute Johns Hopkins University School of Medicine Baltimore Maryland USA

10. Institute of Basic Medical Sciences, Westlake Institute for Advanced Study Hangzhou Zhejiang Province China

Funder

U.S. Department of Defense

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Prostate Cancer Foundation

National Institutes of Health

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24210

Reference72 articles.

1. Cancer statistics, 2020

2. Metastatic Prostate Cancer

3. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

4. Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

5. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo;Journal of Experimental & Clinical Cancer Research;2023-05-20

2. Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer;JCI Insight;2023-04-10

3. The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer;Non-Coding RNA;2022-12-01

4. Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy;The Prostate;2022-08-18

5. Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort;The Prostate;2022-08-03